US FDA reveals plans for single cancer drug regulation centre Scheme is part of US government Cancer Moonshot initiative
US FDA fast-tracks review of Roche's potential MS blockbuster Regulator to make decision by year end.
News Brexit: could European Medicines Agency stay in London? Pharma wants single regulatory system to remain.
News EU regulator wants more advanced therapies Only a handful of products have reached the market in eight years.
News FDA asks for more data on Sarepta's muscular dystrophy drug Regulator asks for more data from ongoing trial.
Cancer Novartis' Afinitor gets new EU cancer use Novartis’ Afinitor has been approved in a new cancer indication in Europe – but faces potential competition from newer drugs.
News Nine more companies sign pricing deals with Trump Nine more pharma groups have agreed to lower the costs of medicines in the US under the Trump administration's most favoured nation (MFN) scheme.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
